Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tuberculosis | 67 | 2024 | 1986 | 5.970 |
Why?
|
Peru | 93 | 2024 | 859 | 3.980 |
Why?
|
Tuberculosis, Pulmonary | 32 | 2024 | 820 | 3.120 |
Why?
|
Mycobacterium tuberculosis | 33 | 2024 | 1886 | 2.270 |
Why?
|
Tuberculosis, Multidrug-Resistant | 24 | 2023 | 923 | 2.140 |
Why?
|
Antitubercular Agents | 30 | 2024 | 1361 | 1.910 |
Why?
|
Isoniazid | 8 | 2022 | 282 | 1.220 |
Why?
|
Latent Tuberculosis | 7 | 2024 | 221 | 0.890 |
Why?
|
Contact Tracing | 12 | 2024 | 267 | 0.820 |
Why?
|
Family Characteristics | 12 | 2024 | 989 | 0.790 |
Why?
|
Rifampin | 10 | 2023 | 332 | 0.770 |
Why?
|
Sputum | 12 | 2024 | 501 | 0.750 |
Why?
|
Nitroimidazoles | 3 | 2022 | 112 | 0.530 |
Why?
|
HIV Infections | 16 | 2024 | 17006 | 0.480 |
Why?
|
Health Personnel | 8 | 2024 | 3266 | 0.430 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2017 | 3934 | 0.410 |
Why?
|
Adolescent | 56 | 2024 | 86765 | 0.390 |
Why?
|
Mass Screening | 9 | 2024 | 5397 | 0.380 |
Why?
|
Professional Competence | 1 | 2014 | 432 | 0.380 |
Why?
|
Prediabetic State | 3 | 2022 | 529 | 0.360 |
Why?
|
Medication Adherence | 5 | 2023 | 2134 | 0.340 |
Why?
|
Humans | 131 | 2024 | 752341 | 0.310 |
Why?
|
Mouth Mucosa | 2 | 2020 | 428 | 0.300 |
Why?
|
Health Services Accessibility | 6 | 2024 | 5281 | 0.300 |
Why?
|
DNA, Bacterial | 4 | 2020 | 1447 | 0.300 |
Why?
|
Antigens, CD1 | 2 | 2021 | 437 | 0.300 |
Why?
|
Young Adult | 40 | 2024 | 57629 | 0.300 |
Why?
|
Child | 42 | 2024 | 78998 | 0.280 |
Why?
|
Pyrazinamide | 2 | 2017 | 55 | 0.280 |
Why?
|
Child, Preschool | 28 | 2024 | 41659 | 0.280 |
Why?
|
Genome, Bacterial | 2 | 2024 | 758 | 0.280 |
Why?
|
BCG Vaccine | 4 | 2018 | 366 | 0.270 |
Why?
|
Adult | 61 | 2024 | 216913 | 0.260 |
Why?
|
Infant | 26 | 2024 | 35673 | 0.260 |
Why?
|
Lost to Follow-Up | 2 | 2024 | 117 | 0.260 |
Why?
|
Oxazoles | 3 | 2022 | 197 | 0.260 |
Why?
|
Delayed Diagnosis | 3 | 2024 | 452 | 0.250 |
Why?
|
Focus Groups | 4 | 2022 | 1360 | 0.250 |
Why?
|
Quantitative Trait Loci | 2 | 2024 | 2072 | 0.250 |
Why?
|
Sensitivity and Specificity | 8 | 2024 | 14586 | 0.250 |
Why?
|
Male | 70 | 2024 | 354881 | 0.240 |
Why?
|
Female | 74 | 2024 | 386053 | 0.230 |
Why?
|
Prevalence | 12 | 2024 | 15506 | 0.230 |
Why?
|
Tuberculin Test | 6 | 2023 | 205 | 0.230 |
Why?
|
Bivalvia | 1 | 2023 | 53 | 0.230 |
Why?
|
Breath Tests | 1 | 2024 | 296 | 0.220 |
Why?
|
Extensively Drug-Resistant Tuberculosis | 1 | 2023 | 85 | 0.220 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2019 | 1898 | 0.190 |
Why?
|
Infant, Newborn | 15 | 2024 | 25914 | 0.190 |
Why?
|
Microbial Sensitivity Tests | 7 | 2023 | 1898 | 0.190 |
Why?
|
Private Sector | 1 | 2024 | 398 | 0.190 |
Why?
|
Transportation | 1 | 2022 | 215 | 0.180 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2021 | 113 | 0.180 |
Why?
|
Esters | 1 | 2021 | 211 | 0.180 |
Why?
|
Trehalose | 1 | 2021 | 88 | 0.180 |
Why?
|
Prisons | 1 | 2022 | 162 | 0.180 |
Why?
|
Cough | 1 | 2024 | 595 | 0.180 |
Why?
|
Prisoners | 1 | 2023 | 301 | 0.180 |
Why?
|
Qualitative Research | 8 | 2023 | 2885 | 0.180 |
Why?
|
Sulfhydryl Compounds | 1 | 2021 | 298 | 0.180 |
Why?
|
Middle Aged | 41 | 2024 | 217019 | 0.170 |
Why?
|
Radiography, Thoracic | 2 | 2024 | 1287 | 0.170 |
Why?
|
HIV Long-Term Survivors | 1 | 2019 | 121 | 0.160 |
Why?
|
Gastric Juice | 1 | 2018 | 61 | 0.160 |
Why?
|
Antigens, CD1d | 1 | 2019 | 217 | 0.160 |
Why?
|
Drug Resistance, Multiple, Bacterial | 3 | 2018 | 578 | 0.160 |
Why?
|
Amides | 1 | 2021 | 450 | 0.160 |
Why?
|
Prospective Studies | 21 | 2024 | 53807 | 0.160 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2023 | 4572 | 0.160 |
Why?
|
Self Disclosure | 1 | 2019 | 248 | 0.160 |
Why?
|
Transients and Migrants | 1 | 2021 | 157 | 0.160 |
Why?
|
Vitamin E Deficiency | 1 | 2018 | 30 | 0.150 |
Why?
|
Antibiotics, Antitubercular | 1 | 2018 | 100 | 0.150 |
Why?
|
Immunoglobulin M | 1 | 2023 | 1519 | 0.150 |
Why?
|
Anti-HIV Agents | 2 | 2024 | 4443 | 0.150 |
Why?
|
Geologic Sediments | 1 | 2018 | 79 | 0.150 |
Why?
|
Specimen Handling | 2 | 2022 | 700 | 0.150 |
Why?
|
Tuberculosis Vaccines | 1 | 2017 | 47 | 0.150 |
Why?
|
National Health Programs | 2 | 2021 | 442 | 0.150 |
Why?
|
Suction | 1 | 2018 | 262 | 0.150 |
Why?
|
Directly Observed Therapy | 1 | 2018 | 138 | 0.150 |
Why?
|
Communicable Disease Control | 2 | 2021 | 843 | 0.150 |
Why?
|
Vitamin A Deficiency | 1 | 2017 | 89 | 0.140 |
Why?
|
Amino Acid Motifs | 1 | 2019 | 930 | 0.140 |
Why?
|
Health Facilities | 1 | 2022 | 571 | 0.140 |
Why?
|
Ethambutol | 1 | 2016 | 59 | 0.140 |
Why?
|
Linkage Disequilibrium | 1 | 2021 | 1989 | 0.140 |
Why?
|
Case-Control Studies | 8 | 2022 | 21841 | 0.140 |
Why?
|
Actigraphy | 1 | 2020 | 513 | 0.140 |
Why?
|
Viral Load | 3 | 2023 | 3297 | 0.130 |
Why?
|
Comprehensive Health Care | 1 | 2017 | 124 | 0.130 |
Why?
|
Hypersensitivity, Immediate | 1 | 2019 | 342 | 0.130 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2019 | 792 | 0.130 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2020 | 606 | 0.130 |
Why?
|
Caregivers | 3 | 2023 | 2172 | 0.130 |
Why?
|
Amidohydrolases | 1 | 2016 | 169 | 0.130 |
Why?
|
Risk Factors | 19 | 2024 | 73412 | 0.130 |
Why?
|
Selection, Genetic | 1 | 2020 | 871 | 0.130 |
Why?
|
Health Literacy | 1 | 2020 | 422 | 0.120 |
Why?
|
Parenting | 1 | 2021 | 684 | 0.120 |
Why?
|
Cross-Sectional Studies | 10 | 2024 | 25535 | 0.120 |
Why?
|
Socioeconomic Factors | 4 | 2022 | 7747 | 0.120 |
Why?
|
Th17 Cells | 1 | 2021 | 775 | 0.120 |
Why?
|
Immunologic Memory | 1 | 2021 | 1324 | 0.120 |
Why?
|
Treatment Outcome | 17 | 2023 | 64245 | 0.120 |
Why?
|
Income | 1 | 2023 | 1864 | 0.120 |
Why?
|
Entamoebiasis | 1 | 2013 | 12 | 0.120 |
Why?
|
Anticholesteremic Agents | 1 | 2021 | 985 | 0.120 |
Why?
|
Protozoan Infections | 1 | 2013 | 38 | 0.120 |
Why?
|
Amebiasis | 1 | 2013 | 33 | 0.120 |
Why?
|
Social Class | 1 | 2023 | 1992 | 0.120 |
Why?
|
Giardiasis | 1 | 2013 | 28 | 0.120 |
Why?
|
Blastocystis Infections | 1 | 2013 | 17 | 0.110 |
Why?
|
Age Factors | 10 | 2021 | 18297 | 0.110 |
Why?
|
Body Height | 1 | 2020 | 1563 | 0.110 |
Why?
|
Social Stigma | 2 | 2023 | 721 | 0.110 |
Why?
|
Bronchiectasis | 1 | 2015 | 133 | 0.110 |
Why?
|
Phylogeny | 1 | 2021 | 2755 | 0.110 |
Why?
|
Vitamin E | 1 | 2018 | 872 | 0.110 |
Why?
|
Urban Population | 2 | 2020 | 2006 | 0.110 |
Why?
|
Diabetes Mellitus | 4 | 2020 | 5839 | 0.110 |
Why?
|
Molecular Epidemiology | 1 | 2015 | 460 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1083 | 0.110 |
Why?
|
Dendritic Cells | 1 | 2024 | 2715 | 0.110 |
Why?
|
Primary Prevention | 1 | 2020 | 1183 | 0.110 |
Why?
|
Feces | 1 | 2019 | 1438 | 0.110 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 779 | 0.110 |
Why?
|
Drug Resistance, Bacterial | 2 | 2017 | 1035 | 0.110 |
Why?
|
Community Health Services | 1 | 2018 | 654 | 0.100 |
Why?
|
Breast Feeding | 1 | 2021 | 1348 | 0.100 |
Why?
|
Disease Progression | 5 | 2021 | 13402 | 0.100 |
Why?
|
Parents | 2 | 2017 | 3502 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1439 | 0.100 |
Why?
|
Mothers | 2 | 2021 | 2175 | 0.100 |
Why?
|
World Health Organization | 3 | 2023 | 1294 | 0.100 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3106 | 0.100 |
Why?
|
Epidemics | 1 | 2017 | 507 | 0.100 |
Why?
|
Cost of Illness | 1 | 2021 | 1912 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2020 | 1373 | 0.090 |
Why?
|
Nutritional Status | 2 | 2016 | 1596 | 0.090 |
Why?
|
Binding Sites | 1 | 2019 | 6028 | 0.090 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4518 | 0.090 |
Why?
|
Mutation, Missense | 1 | 2020 | 2556 | 0.090 |
Why?
|
Medication Errors | 1 | 2017 | 773 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2023 | 10198 | 0.090 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2015 | 3146 | 0.090 |
Why?
|
Clinical Protocols | 3 | 2022 | 1436 | 0.090 |
Why?
|
Logistic Models | 6 | 2023 | 13277 | 0.090 |
Why?
|
Sexual Behavior | 1 | 2019 | 2061 | 0.090 |
Why?
|
Weight Gain | 1 | 2020 | 2330 | 0.090 |
Why?
|
Vitamin D Deficiency | 1 | 2019 | 1368 | 0.090 |
Why?
|
Incidence | 8 | 2020 | 21158 | 0.090 |
Why?
|
Aged | 18 | 2024 | 166562 | 0.090 |
Why?
|
Smoking Cessation | 1 | 2021 | 2077 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2018 | 3788 | 0.080 |
Why?
|
Macrophages | 1 | 2024 | 5693 | 0.080 |
Why?
|
Blood Glucose | 2 | 2021 | 6331 | 0.080 |
Why?
|
Feasibility Studies | 4 | 2020 | 5146 | 0.080 |
Why?
|
Tobacco Smoke Pollution | 1 | 2014 | 809 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2095 | 0.080 |
Why?
|
Public Health | 1 | 2022 | 2644 | 0.080 |
Why?
|
Adaptation, Psychological | 1 | 2019 | 2591 | 0.080 |
Why?
|
Cluster Analysis | 3 | 2021 | 2682 | 0.080 |
Why?
|
T-Lymphocytes | 3 | 2021 | 10036 | 0.080 |
Why?
|
Nucleic Acid Amplification Techniques | 2 | 2023 | 329 | 0.080 |
Why?
|
Interviews as Topic | 1 | 2015 | 2620 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2024 | 15645 | 0.080 |
Why?
|
Health Behavior | 1 | 2019 | 2615 | 0.080 |
Why?
|
Feeding Behavior | 2 | 2017 | 3174 | 0.070 |
Why?
|
Cohort Studies | 9 | 2024 | 40984 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 4 | 2024 | 3117 | 0.070 |
Why?
|
Bacterial Proteins | 1 | 2021 | 3803 | 0.070 |
Why?
|
Emotions | 1 | 2019 | 2693 | 0.070 |
Why?
|
Triage | 2 | 2024 | 977 | 0.070 |
Why?
|
Glucose Tolerance Test | 2 | 2020 | 1169 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 3 | 2024 | 17648 | 0.070 |
Why?
|
Genotype | 5 | 2019 | 12869 | 0.070 |
Why?
|
Drug Therapy, Combination | 3 | 2023 | 6482 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2022 | 3302 | 0.070 |
Why?
|
Sex Factors | 4 | 2021 | 10455 | 0.070 |
Why?
|
Patient-Centered Care | 3 | 2022 | 1412 | 0.070 |
Why?
|
Multivariate Analysis | 5 | 2019 | 12137 | 0.070 |
Why?
|
Social Support | 3 | 2022 | 2118 | 0.070 |
Why?
|
Quality Improvement | 1 | 2021 | 3797 | 0.060 |
Why?
|
Homosexuality, Male | 2 | 2024 | 1253 | 0.060 |
Why?
|
Vitamin D | 1 | 2019 | 3273 | 0.060 |
Why?
|
Area Under Curve | 2 | 2020 | 1613 | 0.060 |
Why?
|
Immunophenotyping | 2 | 2020 | 1861 | 0.060 |
Why?
|
Comorbidity | 2 | 2017 | 10475 | 0.060 |
Why?
|
Psychometrics | 1 | 2014 | 3005 | 0.060 |
Why?
|
Sleep | 1 | 2020 | 4687 | 0.060 |
Why?
|
Treatment Failure | 2 | 2023 | 2635 | 0.060 |
Why?
|
Clofazimine | 1 | 2023 | 36 | 0.060 |
Why?
|
Pilot Projects | 3 | 2022 | 8443 | 0.060 |
Why?
|
Exercise | 1 | 2020 | 5745 | 0.060 |
Why?
|
Longitudinal Studies | 4 | 2024 | 14325 | 0.060 |
Why?
|
Tuberculin | 1 | 2022 | 64 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5279 | 0.050 |
Why?
|
Odds Ratio | 3 | 2023 | 9701 | 0.050 |
Why?
|
Reverse Transcription | 1 | 2022 | 47 | 0.050 |
Why?
|
Smoking | 2 | 2021 | 9029 | 0.050 |
Why?
|
Public Sector | 1 | 2024 | 263 | 0.050 |
Why?
|
Body Mass Index | 2 | 2017 | 12796 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2023 | 79127 | 0.050 |
Why?
|
Pandemics | 4 | 2022 | 8505 | 0.050 |
Why?
|
Electrolytes | 1 | 2022 | 281 | 0.050 |
Why?
|
Fluoroquinolones | 1 | 2023 | 305 | 0.050 |
Why?
|
Pregnancy | 5 | 2023 | 29439 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2021 | 2515 | 0.050 |
Why?
|
Lung | 1 | 2020 | 9898 | 0.050 |
Why?
|
Aged, 80 and over | 7 | 2021 | 58300 | 0.050 |
Why?
|
Factor Analysis, Statistical | 1 | 2023 | 984 | 0.050 |
Why?
|
Microfibrils | 1 | 2020 | 16 | 0.050 |
Why?
|
Neck Pain | 1 | 2022 | 183 | 0.050 |
Why?
|
Weights and Measures | 1 | 2020 | 41 | 0.050 |
Why?
|
Indians, South American | 1 | 2020 | 34 | 0.050 |
Why?
|
X-Rays | 1 | 2021 | 302 | 0.040 |
Why?
|
Internet | 1 | 2012 | 3064 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2022 | 39079 | 0.040 |
Why?
|
Primary Health Care | 1 | 2017 | 4617 | 0.040 |
Why?
|
Mycolic Acids | 1 | 2020 | 54 | 0.040 |
Why?
|
Regression Analysis | 2 | 2020 | 6360 | 0.040 |
Why?
|
Asthma | 1 | 2019 | 6144 | 0.040 |
Why?
|
Hospitals, Public | 1 | 2021 | 196 | 0.040 |
Why?
|
Heredity | 1 | 2020 | 147 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2023 | 851 | 0.040 |
Why?
|
Nasopharynx | 1 | 2022 | 391 | 0.040 |
Why?
|
Glycolipids | 1 | 2020 | 203 | 0.040 |
Why?
|
Lipids | 2 | 2021 | 3328 | 0.040 |
Why?
|
Residence Characteristics | 2 | 2022 | 2020 | 0.040 |
Why?
|
Administration, Oral | 2 | 2017 | 4001 | 0.040 |
Why?
|
Bacterial Typing Techniques | 1 | 2019 | 258 | 0.040 |
Why?
|
Drug Repositioning | 1 | 2020 | 232 | 0.040 |
Why?
|
Genes, MDR | 1 | 2018 | 36 | 0.040 |
Why?
|
Self-Help Groups | 1 | 2019 | 187 | 0.040 |
Why?
|
Self Efficacy | 1 | 2022 | 623 | 0.040 |
Why?
|
Saliva | 1 | 2022 | 801 | 0.040 |
Why?
|
Automation, Laboratory | 1 | 2018 | 102 | 0.040 |
Why?
|
Health Services | 1 | 2023 | 751 | 0.040 |
Why?
|
Condoms | 1 | 2019 | 310 | 0.040 |
Why?
|
Lectins, C-Type | 1 | 2021 | 585 | 0.040 |
Why?
|
Gender Identity | 1 | 2023 | 694 | 0.040 |
Why?
|
Antigen-Presenting Cells | 1 | 2021 | 945 | 0.040 |
Why?
|
Hospitals, General | 1 | 2021 | 767 | 0.040 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9355 | 0.040 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2019 | 474 | 0.030 |
Why?
|
Skin Tests | 1 | 2019 | 637 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2019 | 4717 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2020 | 19894 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2019 | 1165 | 0.030 |
Why?
|
Genetic Variation | 2 | 2024 | 6507 | 0.030 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2018 | 251 | 0.030 |
Why?
|
Mutation | 2 | 2019 | 29705 | 0.030 |
Why?
|
Spirometry | 1 | 2019 | 910 | 0.030 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2019 | 820 | 0.030 |
Why?
|
Biological Evolution | 1 | 2021 | 1064 | 0.030 |
Why?
|
Urinalysis | 1 | 2018 | 367 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2012 | 4631 | 0.030 |
Why?
|
Pregnant Women | 1 | 2020 | 557 | 0.030 |
Why?
|
Educational Status | 1 | 2023 | 2499 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2022 | 907 | 0.030 |
Why?
|
Gene Expression | 2 | 2019 | 7580 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2024 | 11883 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10797 | 0.030 |
Why?
|
Social Environment | 1 | 2019 | 1010 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2019 | 970 | 0.030 |
Why?
|
Risk Assessment | 3 | 2020 | 23783 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2019 | 1112 | 0.030 |
Why?
|
Entamoeba | 1 | 2013 | 5 | 0.030 |
Why?
|
Endolimax | 1 | 2013 | 6 | 0.030 |
Why?
|
Blastocystis hominis | 1 | 2013 | 6 | 0.030 |
Why?
|
Vitamin A | 1 | 2017 | 612 | 0.030 |
Why?
|
Carotenoids | 1 | 2017 | 619 | 0.030 |
Why?
|
Giardia lamblia | 1 | 2013 | 23 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2019 | 1237 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2019 | 3078 | 0.030 |
Why?
|
Appointments and Schedules | 1 | 2018 | 429 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2016 | 626 | 0.030 |
Why?
|
Biological Assay | 1 | 2016 | 631 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2277 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2014 | 507 | 0.030 |
Why?
|
Bacteriological Techniques | 1 | 2014 | 280 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3586 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2019 | 1341 | 0.030 |
Why?
|
Algorithms | 2 | 2023 | 13900 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3124 | 0.030 |
Why?
|
Patient Compliance | 1 | 2022 | 2680 | 0.030 |
Why?
|
Interpersonal Relations | 1 | 2019 | 1420 | 0.030 |
Why?
|
Overweight | 1 | 2023 | 2400 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2020 | 6234 | 0.020 |
Why?
|
Protein Conformation | 1 | 2019 | 3956 | 0.020 |
Why?
|
Self Report | 1 | 2023 | 3647 | 0.020 |
Why?
|
Radiography | 1 | 2022 | 6964 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2018 | 812 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2016 | 1687 | 0.020 |
Why?
|
Adolescent Behavior | 1 | 2019 | 1149 | 0.020 |
Why?
|
Health Expenditures | 1 | 2023 | 2335 | 0.020 |
Why?
|
Computer Systems | 1 | 2012 | 471 | 0.020 |
Why?
|
Disease Transmission, Infectious | 1 | 2016 | 558 | 0.020 |
Why?
|
Counseling | 1 | 2019 | 1542 | 0.020 |
Why?
|
Family | 1 | 2021 | 3165 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2020 | 12447 | 0.020 |
Why?
|
Information Systems | 1 | 2012 | 396 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15130 | 0.020 |
Why?
|
Geographic Information Systems | 1 | 2012 | 278 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2318 | 0.020 |
Why?
|
Monocytes | 1 | 2019 | 2556 | 0.020 |
Why?
|
Empathy | 1 | 2014 | 470 | 0.020 |
Why?
|
Genetic Loci | 1 | 2019 | 2602 | 0.020 |
Why?
|
Anti-Retroviral Agents | 1 | 2019 | 1771 | 0.020 |
Why?
|
Housing | 1 | 2014 | 656 | 0.020 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2018 | 923 | 0.020 |
Why?
|
Time Factors | 3 | 2017 | 39854 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4880 | 0.020 |
Why?
|
Models, Molecular | 1 | 2019 | 5385 | 0.020 |
Why?
|
Epidemiologic Studies | 1 | 2012 | 667 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6501 | 0.020 |
Why?
|
Health Policy | 1 | 2021 | 2656 | 0.020 |
Why?
|
Pain Measurement | 1 | 2018 | 3463 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3560 | 0.020 |
Why?
|
Data Collection | 1 | 2017 | 3302 | 0.020 |
Why?
|
Mental Health | 1 | 2022 | 3150 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2013 | 2572 | 0.020 |
Why?
|
Protein Binding | 1 | 2019 | 9273 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3600 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10177 | 0.020 |
Why?
|
Body Weight | 1 | 2017 | 4606 | 0.020 |
Why?
|
Program Development | 1 | 2012 | 1287 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12455 | 0.020 |
Why?
|
Checklist | 1 | 2012 | 814 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9613 | 0.020 |
Why?
|
Language | 1 | 2014 | 1501 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2019 | 4340 | 0.020 |
Why?
|
Hospitalization | 1 | 2024 | 10627 | 0.010 |
Why?
|
Depression | 1 | 2023 | 7917 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2016 | 3991 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5727 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2019 | 4319 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3547 | 0.010 |
Why?
|
Developing Countries | 1 | 2014 | 2819 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6116 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 7995 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12806 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 13153 | 0.010 |
Why?
|
Chronic Disease | 1 | 2015 | 9158 | 0.010 |
Why?
|
Diet | 1 | 2017 | 7949 | 0.010 |
Why?
|
Models, Statistical | 1 | 2014 | 5049 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15676 | 0.010 |
Why?
|
Mental Disorders | 1 | 2017 | 6694 | 0.010 |
Why?
|
HIV-1 | 1 | 2013 | 6827 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 29327 | 0.010 |
Why?
|
United States | 1 | 2023 | 71442 | 0.010 |
Why?
|
Animals | 1 | 2023 | 166802 | 0.010 |
Why?
|